References
- Cobb LA, Werner JA, Trobaugh GB. Sudden cardiac death. 1. A decade's experience with out-of-hospital resuscitation. II. Outcome of resuscitation, management, and future directions. Mod Concepts Cardiovasc Dis 1980: 49(6–7): 31–6. 37–42
- Ruskin JN, DiMarco JP, Ganui H. Out-of-hospital cardiac arrest: electrophysiologic observations and selection of long-term antiarrhythmic therapy. N Engl J Med 1980: 303(11): 607–13
- Bigger JT Jr, Flelss JL, Kleiger R, et al. The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction. Circulation 1984: 69(2): 250–8
- Beta-Blocker Heart Attack Trial Research Group. A randomized trial of propranolol in patients with acute myocardial infarction. JAMA 1983: 250(20): 2814–9
- Norwegian Multicenter Study Group. Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction. N Engl J Med 1981: 304(14): 801–7
- Kennedy HL, Whitlock JA, Sprague MK, et al. Long-term follow-up of asymptomatic healthy subjects with frequent and complex ventricular ectopy. N Engl J Med 1985: 312(4): 193–7
- Velebit V, Podrid P, Lown B, et al. Aggravation and provocation of ventricular arrhythmias by antiarrhythmic drugs. Circulation 1982: 65(5): 886–94
- Smith WM, Gallagher JJ. Les torsades de pointes: an unusual ventricular arrhythmia. Ann Intern Med 1980: 93(4): 578–84
- Roden DM, Woosley RL. Bostick D, et al. quinidine-induced long QT syndrome: incidence and presenting features. Circulation 1983: 68(Suppl 3): 276
- Hager WD, Fenster P, Mayersohn M, et al Digox-in-quinidine interaction. N Engl J Med 1979: 300(22): 1238–41
- Lima JJ, Boudoulas H, Blanford M. Concentration-dependence of disopyramide binding to plasma protein and its influence on kinetics and dynamics. J Pharmacol Exp Ther 1981: 219(3): 741–7
- Ellrodt AG. Murata GH, Riedinger MS, et al. Severe neutropenia associated with sustained-release procainamide. Ann Intern Med 1984: 100(2): 197–201
- Drayer DE, Lowenthal DT, Woosley RL, et al. Cumulation of pacetylprocainamide, an active metabolite of procainamide, in patients with impaired renal function. Clin Pharm Ther 1977: 22(1): 63–9
- Woosley RL. Drayer DE, Reidenberg MM, et al. Effect of acetylator phenotype on the rate at which procainamide induces antinuclear antibodies and the lupus syndrome. N Engl J Med 1978: 298(21): 1157–9
- Roden DM, Reele SB, Higgins SB, et al. Antiarrhythmic efficacy, pharmacokisnetics and safety of Nacetylprocainamide in man: comparison with procainamide. Am J Cardiol 1980: 46(3): 463–8
- Roden DM, Reele SB, Higgins SB, et al. Tocainide therapy for refractory ventricular arrhythmias. Am Heart J 1980: 100(1): 15–22
- Roden DM, Woosley RL. Tocainide. In: Gould LA. ed. Drug treatment of cardiac arrhythmias. Mt Kisco. NY: Futura Publishing. 1983: 183–92
- Chew CY, Collett J, Singh BN. Mexiletine: a review of its pharmacological properties and therapeutic efficacy in arrhythmias. Drugs 1979: 17(3): 161–81
- Duff HJ, Roden DM, Primm RK. et al. Mexiletine in the treatment of resistant ventricular arrhythmias: enhancement of efficacy and reduction of dose-related side effects by combination with quinidine. Circulation 1983: 67(5): 1124–8
- Roden DM, Reele SB, Higgins SB, et al. Total suppression of ventricular arrhythmias by encainide: pharmacokinetic and electrocardiographic characteristics. N Engl J Med 1980: 302(16): 877–82
- Duff HJ, Roden DM, Maffucci RJ, et al. Suppression of resistant ventricular arrhythmias by twice daily dosing with flecainide. Am J Cardiol 1981: 48(6): 1133–40
- Winkle RA. Mason JW, Griffin JC, et al. Malignant ventricular tachyarrhythmias associated with the use of encainide. Am Heart J 1981: 102(5): 857–64
- Oetgen WJ, Tibbits PA, Abt ME, et al. Clinical and electrophysiologic assessment of oral flecainide acetate for recurrent ventricular tachycardia: evidence for exacerbation of electrical instability. Am J Cardiol 1983: 52(7): 746–50
- Woosley RL, Roden DM. Importance of metabolites in antiarrhythmic therapy. Am J Cardiol 1983: 52(6): 3–7C
- Guehler J, Gornick CC. Tobler HG, et al. Electrophysiolcgic effects of flecainide acetate and its major metabolites in the canine heart. Am J Cardiol 1985: 55(6): 807–12
- Zipes DP, Prystowsky EN, Heger JJ. Amiodarone: electrophysiologic actions, pharmacokinetics, and clinical effects. J Am Coll Cardiol 1984: 3(4): 1059–71
- Simon JB, Manley PN, Brien JP, et al. Amiodarone hepatotoxicity simulating alcoholic liver disease. N Engl J Med 1984: 311 (3): 167–72